Back
Apellis Pharmaceuticals Stock Predictions

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
33
APLS
Apellis Pharmaceuticals
Last Price:
$17.84
Seasonality Move:
-0.62%
7 Day Trial
ALL ACCESS PASS
$
7

Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaApellis Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 18.3% based on the past 7 years of stock performance.
-
Apellis Pharmaceuticals has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Apellis Pharmaceuticals Stock Undervalued?The current Apellis Pharmaceuticals [APLS] share price is $17.76. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 18.3% based on the past 7 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
33
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
-
Apellis Pharmaceuticals has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
42.47
52-Week Low:
16.10
Prediction Charts
Market Cap:
2.2B
Price in USD:
17.76
Volume:
1.4M
Beta:
0.90
Technical Analysis
SMA50:
18.29
SMA100:
22.26
SMA200:
26.93
52-Wk Change:
-55.68%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?Yes, Apellis Pharmaceuticals is a publicly traded company.
-
What is the Apellis Pharmaceuticals stock quote today?The Apellis Pharmaceuticals stock price is 17.76 USD today.
-
How to buy Apellis Pharmaceuticals stock online?You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-30 | 17.37 | 16.93 | 17.37 | 16.69 |
Jun-2 | 17.18 | 19.14 | 19.51 | 17.15 |
Jun-3 | 19.06 | 18.82 | 19.73 | 18.81 |
Jun-4 | 18.95 | 18.51 | 19.29 | 18.45 |
Jun-5 | 18.50 | 19.10 | 19.71 | 18.26 |
Jun-6 | 19.33 | 19.28 | 19.71 | 19.14 |
Jun-9 | 19.67 | 19.39 | 19.93 | 19.27 |
Jun-10 | 19.48 | 19.58 | 19.96 | 19.30 |
Jun-11 | 19.80 | 19.27 | 19.90 | 19.18 |
Jun-12 | 19.20 | 19.26 | 19.32 | 18.75 |
Jun-13 | 19.01 | 18.83 | 19.15 | 18.51 |
Jun-16 | 18.77 | 18.30 | 18.77 | 18.00 |
Jun-17 | 18.17 | 17.76 | 18.29 | 17.70 |
Jun-18 | 17.75 | 17.76 | 17.94 | 17.57 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.